[go: up one dir, main page]

NO20031141D0 - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20031141D0
NO20031141D0 NO20031141A NO20031141A NO20031141D0 NO 20031141 D0 NO20031141 D0 NO 20031141D0 NO 20031141 A NO20031141 A NO 20031141A NO 20031141 A NO20031141 A NO 20031141A NO 20031141 D0 NO20031141 D0 NO 20031141D0
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20031141A
Other languages
English (en)
Other versions
NO20031141L (no
Inventor
Pankaj Agarwal
John P Cogswell
Ying-Ta Lai
Shelby A Martensen
Randall F Smith
Jay C Strum
Qing Xie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20031141D0 publication Critical patent/NO20031141D0/no
Publication of NO20031141L publication Critical patent/NO20031141L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20031141A 2000-09-13 2003-03-12 Nye forbindelser NO20031141L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23246300P 2000-09-13 2000-09-13
US23245500P 2000-09-13 2000-09-13
US23729300P 2000-10-02 2000-10-02
US24626900P 2000-11-07 2000-11-07
US25204900P 2000-11-20 2000-11-20
PCT/US2001/028462 WO2002022802A1 (en) 2000-09-13 2001-09-13 Novel compounds

Publications (2)

Publication Number Publication Date
NO20031141D0 true NO20031141D0 (no) 2003-03-12
NO20031141L NO20031141L (no) 2003-05-09

Family

ID=27540000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031141A NO20031141L (no) 2000-09-13 2003-03-12 Nye forbindelser

Country Status (16)

Country Link
US (1) US20070238151A1 (no)
EP (1) EP1317538A4 (no)
JP (1) JP2004508825A (no)
KR (1) KR20030033055A (no)
CN (2) CN1474869A (no)
AU (2) AU9261901A (no)
BR (1) BR0113820A (no)
CA (1) CA2421303A1 (no)
CZ (1) CZ2003722A3 (no)
HU (1) HUP0400016A3 (no)
IL (1) IL154725A (no)
MX (1) MXPA03002180A (no)
NO (1) NO20031141L (no)
NZ (2) NZ534259A (no)
PL (1) PL361691A1 (no)
WO (1) WO2002022802A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US7049403B2 (en) 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
US20030166522A1 (en) * 2000-12-12 2003-09-04 Ketchum Karen A. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CN1252257C (zh) * 2001-03-02 2006-04-19 复旦大学 人类g型溶菌酶、其编码序列、制法及用途
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
US7396662B2 (en) * 2001-12-19 2008-07-08 Immunex Corporation C-type lectin polypeptides
WO2003091414A2 (en) * 2002-04-26 2003-11-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp8
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
EP2248899B8 (en) 2003-03-19 2015-07-15 Biogen MA Inc. NOGO receptor binding protein
US20060259988A1 (en) * 2003-03-31 2006-11-16 Darla Onichtchouk Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
EA009607B1 (ru) * 2003-05-21 2008-02-28 Арес Трейдинг С.А. Tnf-подобный секретируемый белок
EP1636384A4 (en) * 2003-06-20 2007-03-07 Amgen Inc GENEAVIFICATION AND OVEREXPRESSION IN CANCER
EP2474317A1 (en) 2004-06-24 2012-07-11 Biogen Idec MA Inc. Treatment of conditions involving demyelination
US9093121B2 (en) 2006-02-28 2015-07-28 The Invention Science Fund I, Llc Data management of an audio data stream
US10003762B2 (en) 2005-04-26 2018-06-19 Invention Science Fund I, Llc Shared image devices
WO2007008547A2 (en) 2005-07-08 2007-01-18 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
JP2011527572A (ja) 2008-07-09 2011-11-04 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｌｉｎｇｏ抗体または断片を含む組成物
DK2501716T3 (en) * 2009-11-19 2015-04-07 Solis Biodyne Oü Formations to increase polypeptidstabilitet and activity and related practices
JP2015518829A (ja) 2012-05-14 2015-07-06 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． 運動ニューロンに関する状態の処置のためのｌｉｎｇｏ−２アンタゴニスト
AU2016205197B2 (en) 2015-01-08 2021-10-21 Biogen Ma Inc. LINGO-1 antagonists and uses for treatment of demyelinating disorders
CN119351338A (zh) * 2023-09-15 2025-01-24 士泽生物医药（苏州）有限公司 一种表达cd300ld的低免疫原性细胞及其制备方法
CN118108790B (zh) * 2024-03-25 2024-11-05 中国农业大学 一种具glp-1受体激动剂活性的乳清蛋白源降血糖肽的制备及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
US7049403B2 (en) * 2000-04-21 2006-05-23 Takeda Pharmaceutical Company Limited Insulin/IGF/relaxin family polypeptides and DNAS thereof
JP3785029B2 (ja) * 2000-08-04 2006-06-14 株式会社山武 制御装置および制御方法
JP2004537972A (ja) * 2000-12-18 2004-12-24 インサイト・ゲノミックス・インコーポレイテッド 細胞接着タンパク質
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
AU9261901A (en) 2002-03-26
IL154725A (en) 2003-12-23
KR20030033055A (ko) 2003-04-26
EP1317538A4 (en) 2005-04-06
CN1680441A (zh) 2005-10-12
PL361691A1 (en) 2004-10-04
NO20031141L (no) 2003-05-09
NZ534259A (en) 2006-05-26
MXPA03002180A (es) 2004-12-13
CZ2003722A3 (en) 2004-03-17
JP2004508825A (ja) 2004-03-25
CN1474869A (zh) 2004-02-11
AU2001292619B2 (en) 2006-01-12
BR0113820A (pt) 2003-06-24
NZ524328A (en) 2004-09-24
HUP0400016A2 (hu) 2004-04-28
IL154725A0 (en) 2003-10-31
EP1317538A1 (en) 2003-06-11
WO2002022802A1 (en) 2002-03-21
HUP0400016A3 (en) 2006-01-30
US20070238151A1 (en) 2007-10-11
CA2421303A1 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
NO20026064L (no) Nye forbindelser
NO20023932L (no) Nye forbindelser
NO20040014L (no) Nye forbindelser
NO20041003L (no) Nye forbindelser
NO20034665L (no) Nye forbindelser
NO20014518D0 (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20035428D0 (no) Nye anti-ineffektiver
NO20034992D0 (no) Nye 4-aninlinokinolin-3-karboksamider
NO20021436L (no) Nye forbindelser
NO20025151D0 (no) Nye forbindelser
PT1259508E (pt) Novos biarilcarboxamidas
ATE307121T1 (de) Substituierte arylpyrazine
NO20031141D0 (no) Nye forbindelser
NO20034970D0 (no) Nye arylheteroalkylaminderivater
AR028393A1 (es) Iminoazidas substituidas
NO20020810L (no) Nye fenylpiperaziner
NO20015383L (no) Nye forbindelser
NO20026162L (no) Nye forbindelser
NO20041185L (no) Nye sykloheksylsulfoner
NO20026081D0 (no) Nye forbindelser
ATE365721T1 (de) Substituierte benzoylcyclohexenone
NO20030274L (no) Nye aryleten-sulfonamider
AR028302A1 (es) Feniluracilos substituidos
NO20015374L (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application